CervoMed (CRVO) Assets Average (2011 - 2026)
CervoMed (CRVO) posted Assets Average of $19.0 million for Q1 2026, down 28.97% sequentially from $26.7 million in Q4 2025, and down 53.47% YoY from $40.8 million in Q1 2025.
CervoMed (CRVO) Assets Average (2011 - 2026) Analysis & Trends
CervoMed has reported Assets Average for 15 years, with the latest figure at $19.0 million in Q1 2026.
- Quarterly Assets Average fell 53.47% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (down 53.47% YoY) and the FY2025 annual result came in at $33.0 million, up 24.33% from the prior year.
- Assets Average eased to $19.0 million in Q1 2026 per CRVO's latest filing, from $26.7 million in the prior quarter.
- Over five years, Assets Average peaked at $51.0 million in Q3 2024 and troughed at $3.7 million in Q2 2023.
- A 5-year average of $25.4 million and a median of $27.8 million in 2022 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2024: Assets Average tumbled 88.66% in 2023, then soared 737.31% in 2024.
- Over 5 years, Assets Average stood at $15.2 million in 2022, then retreated by 27.79% to $11.0 million in 2023, then soared by 317.83% to $46.0 million in 2024, then tumbled by 41.84% to $26.7 million in 2025, then retreated by 28.97% to $19.0 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $19.0 million, $26.7 million, and $34.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | CervoMed | 26.12 Mn | 26.12 Mn | - | 20.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.55 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 26.74 Mn |
| Sep 30, 2025 | 34.35 Mn |
| Jun 30, 2025 | 38.33 Mn |
| Mar 31, 2025 | 40.83 Mn |
| Dec 31, 2024 | 45.98 Mn |
| Sep 30, 2024 | 51.04 Mn |
| Jun 30, 2024 | 30.59 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 11.01 Mn |
| Sep 30, 2023 | 7.70 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 15.24 Mn |
| Sep 30, 2022 | 27.75 Mn |
| Jun 30, 2022 | 31.38 Mn |
| Mar 31, 2022 | 35.71 Mn |
| Dec 31, 2021 | 39.36 Mn |
| Sep 30, 2021 | 46.80 Mn |